Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia

Overview of attention for article published in Clinical Cancer Research, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 22 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 34 X posts from 22 X users, with an upper bound of 96,568 followers.

The authors of "Integrated Human and Murine Clinical Study Establi…" (https://t.co/LCjkahVS9m) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #reproducibility #ReproducibleResearch

“Myeloid “Leukaemia or “Myelomonocytic”, the latter being a medium to disenfranchise XMRV narratives…..hmmm

RT @md_padron: Thank you @NCICancerBio for highlighting our work! @MoffittNews @MoffittResearch

Phase 1/2 Study: Ruxolitinib for the treatment of CMML. https://t.co/fWUzCHGewo https://t.co/MbRkOjGXJI

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.